Baseline 3 months follow up with levothyroxine 3 months follow up with levothyroxine P-value 6 months Follow up with levothyroxine P-value
Total population of subclinical hypothyroidism (n=18) Total population of subclinical hypothyroidism (n=18) Total population of subclinical hypothyroidism (n=18) Total population of subclinical hypothyroidism (n=18) Total population of subclinical hypothyroidism (n=18) Total population of subclinical hypothyroidism (n=18) Total population of subclinical hypothyroidism (n=18)
RCCA intima-media 0.486 ± 0.106 0.403 ± 0.106 0.403 ± 0.106 0.03 0.350 ± 0.008 0.02
LCCA intima-media 0.511 ± 0.144 0.421 ± 0.125 0.421 ± 0.125 0.02 0.370 ± 0.010 0.01
Subclinical hypothyroidism with TSH ˂10 µUI/ml (n=13) Subclinical hypothyroidism with TSH ˂10 µUI/ml (n=13) Subclinical hypothyroidism with TSH ˂10 µUI/ml (n=13) Subclinical hypothyroidism with TSH ˂10 µUI/ml (n=13) Subclinical hypothyroidism with TSH ˂10 µUI/ml (n=13) Subclinical hypothyroidism with TSH ˂10 µUI/ml (n=13) Subclinical hypothyroidism with TSH ˂10 µUI/ml (n=13)
RCCA intima-media 0.496 ± 0.106 0.496 ± 0.106 0.382 ± 0.174 0.03 0.330 ± 0.060 0.02
LCCA intima-media 0.486 ± 0.107 0.486 ± 0.107 0.410 ± 0.079 0.005 0.342 ± 0.088 .002